197 related articles for article (PubMed ID: 29175642)
1. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
Yamamoto E; Miyazaki S; Aoyama C; Kato M
Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
[TBL] [Abstract][Full Text] [Related]
2. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
Ansar SM; Mudalige T
Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and evaluation of doxorubicin hydrochloride liposomes modified by poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate].
Zhang D; Li JY; Wang XC; Yue HX; Hu MN; Yu X; Xu H
Yao Xue Xue Bao; 2015 Sep; 50(9):1174-9. PubMed ID: 26757556
[TBL] [Abstract][Full Text] [Related]
4. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N
Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769
[TBL] [Abstract][Full Text] [Related]
5. Determination of non-liposomal and liposomal doxorubicin in plasma by LC-MS/MS coupled with an effective solid phase extraction: In comparison with ultrafiltration technique and application to a pharmacokinetic study.
Xie Y; Shao N; Jin Y; Zhang L; Jiang H; Xiong N; Su F; Xu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():149-160. PubMed ID: 29175695
[TBL] [Abstract][Full Text] [Related]
6. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
[TBL] [Abstract][Full Text] [Related]
7. Determination of Nonspherical Morphology of Doxorubicin-Loaded Liposomes by Atomic Force Microscopy.
Takahashi N; Higashi K; Ueda K; Yamamoto K; Moribe K
J Pharm Sci; 2018 Feb; 107(2):717-726. PubMed ID: 29031955
[TBL] [Abstract][Full Text] [Related]
8. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
9. Rapid scale-up and production of active-loaded PEGylated liposomes.
Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
[TBL] [Abstract][Full Text] [Related]
10. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
11. Heating treatments affect the thermal behaviour of doxorubicin loaded in PEGylated liposomes.
Perinelli DR; Cespi M; Bonacucina G; Rendina F; Palmieri GF
Int J Pharm; 2017 Dec; 534(1-2):81-88. PubMed ID: 28993166
[TBL] [Abstract][Full Text] [Related]
12. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
13. Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs.
Schilt Y; Berman T; Wei X; Barenholz Y; Raviv U
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):108-19. PubMed ID: 26391840
[TBL] [Abstract][Full Text] [Related]
14. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of doxorubicin liposomes.
Niu G; Cogburn B; Hughes J
Methods Mol Biol; 2010; 624():211-9. PubMed ID: 20217598
[TBL] [Abstract][Full Text] [Related]
17. Fast and versatile analysis of liposome encapsulation efficiency by nanoParticle exclusion chromatography.
Bian J; Girotti J; Fan Y; Levy ES; Zang N; Sethuraman V; Kou P; Zhang K; Gruenhagen J; Lin J
J Chromatogr A; 2022 Jan; 1662():462688. PubMed ID: 34915190
[TBL] [Abstract][Full Text] [Related]
18. A Density-Changing Centrifugation Method for Efficient Separation of Free Drugs from Drug-Loaded Particulate Delivery Systems.
Han L; Zhan H; Sun X; Zhang ZR; Deng L
AAPS J; 2019 Feb; 21(3):33. PubMed ID: 30805793
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
Kibria G; Hatakeyama H; Sato Y; Harashima H
Int J Pharm; 2016 Jul; 509(1-2):178-187. PubMed ID: 27234700
[TBL] [Abstract][Full Text] [Related]
20. High-Performance Liquid Chromatography (HPLC) Quantification of Liposome-Delivered Doxorubicin in Arthritic Joints of Collagen-Induced Arthritis Rats.
Niu H; Xu M; Li S; Chen J; Luo J; Zhao X; Gao C; Li X
Med Sci Monit Basic Res; 2017 Apr; 23():150-158. PubMed ID: 28408733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
